Cargando…
Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients
Metallo-beta-lactamases-producing (MBL) Enterobacterales is a growing problem worldwide. The optimization of antibiotic therapy is challenging. The pivotal available therapeutic options are either the combination of ceftazidime/avibactam and aztreonam or cefiderocol. Colistin, fosfomycin, tetracycli...
Autores principales: | Timsit, Jean-François, Wicky, Paul-Henri, de Montmollin, Etienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868391/ https://www.ncbi.nlm.nih.gov/pubmed/35203747 http://dx.doi.org/10.3390/antibiotics11020144 |
Ejemplares similares
-
Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens
por: Thy, Michaël, et al.
Publicado: (2023) -
Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review
por: Wicky, Paul-Henri, et al.
Publicado: (2023) -
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
por: de Montmollin, Etienne, et al.
Publicado: (2021) -
Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing
por: Lo, Stéphane, et al.
Publicado: (2022) -
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults
por: Patrier, Juliette, et al.
Publicado: (2022)